SEC Form 4 · accession 0001078782-19-000221
Zivo Bioscience, Inc. · ZIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher D. Maggiore
Director · 10% Owner
Period of report
Mar 8, 2019
Accepted (ET)
Mar 13, 2019 · 6:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001101026
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 8, 2019 | P | 50,000 | $0.10 | A | 21,349,420 | D | |
| Common Stock | Mar 11, 2019 | P | 10,000 | $0.11 | A | 21,359,420 | D | |
| Common Stock | Mar 12, 2019 | P | 30,000 | $0.11 | A | 21,389,420 | D |
Table II — derivative securities
No Table II lines on this filing.